ReviewFrontiers in oncology2025

Comparing the risk of cardiovascular disease between degarelix and gonadotropin-releasing hormone agonists:a systematic review and meta-analysis.

Wencong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.